Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tissue-Specific Molecular Biomarker Signatures of Type 2 Diabetes: An Integrative Analysis of Transcriptomics and Protein–Protein Interaction Data

1 Sept 2015

Abstract excerpt

Type 2 diabetes mellitus is a major global public health burden. A complex metabolic disease, type 2 diabetes affects multiple different tissues, demanding a "systems medicine" approach to biomarker and novel diagnostic discovery, not to mention data integration across omics-es. In the present study, transcriptomics data from different tissues including beta-cells, pancreatic islets, arterial tissue, peripheral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Metabolism, Diabetes, and Cancer
Share to Pancreatic function and diabetes
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26348713
DOI: 10.1089/omi.2015.0088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tissue-Specific Molecular Biomarker Signatures of Type 2 Diabetes: An Integrative Analysis of Transcriptomics and Protein–Protein Interaction DataPMID 26348713Read ↗

Metabolic Network Topology Reveals Transcriptional Regulatory Signatures of Type 2 DiabetesSemantic proximity Read ↗

Identification of biomarkers for the diagnosis of type 2 diabetes mellitus with metabolic associated fatty liver disease by bioinformatics analysis and experimental validationSemantic proximity Read ↗

From omics to AI —mapping the pathogenic pathways in type 2 diabetesSemantic proximity Read ↗

Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.Semantic proximity Read ↗

Multi-omics profiling: the way toward precision medicine in metabolic diseasesSemantic proximity Read ↗

Differently Expressed Genes (DEGs) Relevant to Type 2 Diabetes Mellitus Identification and Pathway Analysis via Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis.Semantic proximity Read ↗

In Silico Metabolic Modeling Reveals Muscle Metabolite Markers of Insulin Resistance In Newly Diagnosed Diabetic PatientsSemantic proximity Read ↗

Examination of the Complex Molecular Landscape in Obesity and Type 2 DiabetesSemantic proximity Read ↗

Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertensionSemantic proximity Read ↗

Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 DiabetesSemantic proximity Read ↗

In Silico Metabolic Modeling Reveals Potential Muscle Metabolite Markers of Insulin Resistance in Newly Diagnosed Diabetic PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.